$13.090
0.000 (0.00%)Zum Schluss
- High
- 13.110
- Open
- 13.090
- VWAP
- 13.09
- Vol
- 19.38M
- Mkt Cap
- 551.63M
- Low
- 13.065
- Amount
- 253.69M
- EV/EBITDA, TTM
- 238.72
Paragon 28, Inc. is a medical device company. The Company develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace. Its products and product families include plates and plating systems, screws, staples, and nails to address all foot and ankle procedures, including fracture fixation, forefoot, or hallux valgus, which includes bunion and hammertoe, ankle, flatfoot, or progressive collapsing foot deformity (PCDF), Charcot foot and Ortho biologics. It provides a comprehensive portfolio of solutions that includes surgical implants and disposables, as well as surgical instrumentation. The Company’s suite of surgical solutions comprises 75 product systems, including approximately 9,200 SKUs, which comprises of approximately 6,800 implants, 1,400 instruments and 1,000 disposable and other SKUs. Its products are available in a variety of sizes and configurations to suit the individual patient’s anatomical and surgical requirements.
Bewertungskennzahlen
Event-Zeitleiste
News
7.004-09PRnewswireSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AZEK, BRDG, FNA on Behalf of Shareholders
7.004-02Globenewswire$TOCKHOLDER ALERT: The M&A Class Action Firm Urges Shareholders of FNA, BECN, QTRX, PLYA to Take Action
7.004-01PRnewswireSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MHLD, TURN, FNA, PTMN on Behalf of Shareholders
4.504-01NASDAQ.COMAfter Hours Most Active for Apr 17, 2025 : INTC, CMCSA, KMI, NVDA, CCL, MRK, FNA, WBD, QQQ, T, VICI, TLT
7.003-28GlobenewswireSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMPS, FNA, ML, JWN on Behalf of Shareholders
FNA FAQ — answered by Alphio AI
Paragon 28, Inc. is a medical device company. The Company develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace. Its products and product families include plates and plating systems, screws, staples, and nails to address all foot and ankle procedures, including fracture fixation, forefoot, or hallux valgus, which includes bunion and hammertoe, ankle, flatfoot, or progressive collapsing foot deformity (PCDF), Charcot foot and Ortho biologics. It provides a comprehensive portfolio of solutions that includes surgical implants and disposables, as well as surgical instrumentation. The Company’s suite of surgical solutions comprises 75 product systems, including approximately 9,200 SKUs, which comprises of approximately 6,800 implants, 1,400 instruments and 1,000 disposable and other SKUs. Its products are available in a variety of sizes and configurations to suit the individual patient’s anatomical and surgical requirements. It operates in the Healthcare sector (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry).
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.